Table 2 Labour, delivery, and maternal and perinatal outcomes (mean ± SD or median [IQR] N (%) unless otherwise specified).

From: Do lower antenatal blood pressure cut-offs in pregnant women with obesity identify those at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of data from the UK Pregnancies Better Eating and Activity Trial (UPBEAT)

  

Antenatal BP (mmHg)a

  

‘Normal BP’

‘Elevated BP’

‘Stage 1 HTN’

‘Stage 2 HTN’ Non-severe

‘Stage 2 HTN’ Severe

 

Overall

<120/<80

120–129/<80

130–139/80–89

≥140/≥90

≥160/≥110

 

N = 1520

(N = 166)

(N = 252)

(N = 614)

(N = 426)

(N = 62)

Labour and delivery

 GA at delivery (wk)

39 ± 2.3

39 ± 2.4

39 ± 2.4

39 ± 2.4

39 ± 2.1

38 ± 3.0

 Labour induction

526 (34.6%)

36 (21.7%)

74 (29.4%)

202 (34.0%)

172 (40.4%)

42 (67.7%)

Mode of delivery

 Unassisted vaginal

798 (52.5%)

107 (64.5%)

145 (57.5%)

327 (53.3%)

196 (46.0%)

23 (37.1%)

 Assisted vaginal

178 (11.7%)

13 (7.8%)

31 (12.3%)

70 (11.4%)

54 (12.7%)

10 (16.1%)

 Caesarean

544 (35.8%)

46 (27.7%)

76 (30.2%)

217 (35.3%)

176 (41.3%)

29 (46.8%)

Maternal complications and co-morbidities

 

 Gestational hypertension

78 (5.1%)

0/153

2/245

4/597 (2.3%)

54/420 (12.7%)

18/62 (29.0%)

 Pre-eclampsia

54 (3.6%)

0/153

0/247

1/603

30/424 (7.0%)

23/62 (37.1%)

 Maternal death

0

0

0

0

0

0

 Placental abruption

9 (0.6%)

1 (0.6%)

1 (0.4%)

2 (0.3%)

3 (0.7%)

2 (3.2%)

 PPH ≥ 1000 mL

200 (13.2%)

15 (9.0%)

23 (9.1%)

78 (12.7%)

68 (15.9%)

16 (25.8%)

 GDM

326 (21.4%)

21 (12.7%)

42 (16.7%)

130 (21.1%)

115 (27.0%)

18 (29.0%)

 Missing

38 (2.5%)

12 (7.2%)

7 (2.8%)

16 (2.6%)

4 (0.9%)

0

Perinatal outcomes

 

 Stillbirth

10 (0.7%)

1 (0.6%)

3 (1.2%)

3 (0.5%)

2 (0.4%)

1 (1.6%)

 Neonatal death

5 (0.3%)

1 (0.6%)

1 (0.4%)

0

3 (0.7%)

1 (1.6%)

Missing

18 (1.2%)

7 (4.2%)

5 (1.9%)

4 (0.7%)

1 (0.2%)

0

 Birth at <34 weeks

36 (2.4%)

6 (3.6%)

3 (1.2%)

16 (2.6%)

7 (1.6%)

4 (6.5%)

Birth at <37 weeks

99 (6.5%)

13 (7.8%)

16 (6.3%)

36 (5.9%)

35 (8.2%)

9 (14.5%)

Gender

 Male

767 (50.2%)

84 (50.6%)

137 (54.4%)

294 (47.9%)

227 (53.3%)

25 (40.3%)

 Female

752 (49.5%)

82 (49.4%)

114 (45.2%)

320 (52.0%)

199 (46.7%)

37 (59.7%)

Birthweight (g)

 <10th centile [WHO]

94 (6.2%)

10 (6.0%)

13 (5.2%)

33 (5.4%)

29 (6.8%)

9 (14.5%)

 <5th centile [WHO]

43 (2.8%)

3 (1.8%)

7 (2.7%)

14 (2.3%)

14 (3.3%)

5 (22.6%)

 >90th centile [WHO]

180 (11.8%)

23 (13.9%)

33 (13.1%)

67 (10.9%)

51 (12.0%)

6 (9.7%)

 >95th centile [WHO]

93 (6.1%)

11 (6.6%)

15 (5.9%)

37 (6.0%)

27 (6.3%)

3 (4.8%)

 Apgar score <7 at 5 min

32 (2.1%)

4 (2.4%)

7 (2.7%)

8 (1.3%)

10 (2.3%)

3 (4.8%)

Missing

26 (1.7%)

7 (4.2%)

5 (1.9%)

11 (1.8%)

1 (0.2%)

0

Neonatal care admission

120 (7.9%)

15 (9.0%)

14 (5.5%)

38 (6.2%)

53 (12.4%)

9 (14.5%)

 >48 h

64 (4.2%)

8 (4.8%)

11 (4.4%)

27 (4.4%)

24 (5.6%)

6 (9.7%)

 Mechanical ventilation

40

5

5

14

11

5

  1. APH antepartum haemorrhage, ART artificial reproductive technologies, BP blood pressure, GDM gestational diabetes mellitus, HDP hypertensive disorder of pregnancy, NA not applicable, PPH postpartum haemorrhage, SGA small for gestational age.
  2. aAs assessed at outpatient antenatal visits or medical assessment unit visits prior to the delivery admission. BP was categorised according to the 2017 American College of Cardiology/American Heart Association criteria as follows: ‘Normal BP’ (sBP < 120 mmHg and dBP < 80 mmHg), ‘Elevated BP’ (sBP 120–129 mmHg but dBP < 80 mmHg), ‘Stage 1 hypertension’ (sBP 130–139 mmHg and/or dBP 80–89 mmHg), and ‘Stage 2 hypertension’ (sBP ≥ 140 mmHg and/or dBP ≥ 90 mmHg).